Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.

EMBO Mol Med · 2022 · PMC9549706 · PMID 36069059

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the patient groups with an initial GBM diagnosis (iGBM) or with a recurrent GBM (rGBM), the sFn14 concentration was in a similar range but showed a trend to an increase in the rGBM group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.